682
Participants
Start Date
July 1, 2008
Primary Completion Date
May 21, 2010
Study Completion Date
November 16, 2010
SB-742457 15mg
SB-742457 - 15mg added to existing donepezil treatment
SB-742457 35mg
SB-742457 - 35mg added to existing donepezil
Placebo
Placebo added to existing donepezil
donepezil 5-10mg
existing donepezil treatment
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Kogarah
GSK Investigational Site, Santa Fe
GSK Investigational Site, Heidelberg West
GSK Investigational Site, Kew
GSK Investigational Site, Ballarat
GSK Investigational Site, Herston
GSK Investigational Site, Córdoba
GSK Investigational Site, Woodville
GSK Investigational Site, Nedlands
GSK Investigational Site, Prague
GSK Investigational Site, Turin
GSK Investigational Site, Berlin
GSK Investigational Site, Castellon
GSK Investigational Site, Berlin
GSK Investigational Site, Syracuse
GSK Investigational Site, Berlin
GSK Investigational Site, Prague
GSK Investigational Site, Schwerin
GSK Investigational Site, Schwerin
GSK Investigational Site, San Sebastián
GSK Investigational Site, Rho
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Castellanza (VA)
GSK Investigational Site, Brescia
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Mělník
GSK Investigational Site, Madrid
GSK Investigational Site, Achim
GSK Investigational Site, Murcia
GSK Investigational Site, Hallandale
GSK Investigational Site, Hialeah
GSK Investigational Site, Valdagno (VI)
GSK Investigational Site, Salamanca
GSK Investigational Site, Verona
GSK Investigational Site, Memphis
GSK Investigational Site, Columbus
GSK Investigational Site, Bochum
GSK Investigational Site, Valencia
GSK Investigational Site, Baracaldo/Vizcaya
GSK Investigational Site, Aachen
GSK Investigational Site, Pardubice
GSK Investigational Site, Bad Honnef
GSK Investigational Site, Lido Di Camaiore (LU)
GSK Investigational Site, Pisa
GSK Investigational Site, Bad Homburg
GSK Investigational Site, Alzenau in Unterfranken
GSK Investigational Site, Chieti Scalo
GSK Investigational Site, Stuttgart
GSK Investigational Site, Tübingen
GSK Investigational Site, Ellwangen
GSK Investigational Site, Tulsa
GSK Investigational Site, Austin
GSK Investigational Site, Napoli
GSK Investigational Site, San Felice A Cancello - Caserta
GSK Investigational Site, Munich
GSK Investigational Site, Unterhaching
GSK Investigational Site, Litchfield Park
GSK Investigational Site, Ulm
GSK Investigational Site, Günzburg
GSK Investigational Site, Rancho Mirage
GSK Investigational Site, Regensburg
GSK Investigational Site, Fresno
GSK Investigational Site, San Francisco
GSK Investigational Site, Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, Paterson
GSK Investigational Site, Bennington
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Ciudad de Buenos Aires
GSK Investigational Site, La Plata
GSK Investigational Site, Saint John
GSK Investigational Site, Kentville
GSK Investigational Site, Ottawa
GSK Investigational Site, Peterborough
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Greenfield Park
GSK Investigational Site, Montreal
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Québec
GSK Investigational Site, Viña del Mar
GSK Investigational Site, Santiago
GSK Investigational Site, Olomouc
GSK Investigational Site, Ostrava
GSK Investigational Site, Pilsen
GSK Investigational Site, Prague
GSK Investigational Site, Dresden
GSK Investigational Site, Dresden
GSK Investigational Site, Jena
GSK Investigational Site, Cassino (FR)
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Perugia
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Burgos
GSK Investigational Site, San Vicente Del Raspeig/Alicante
Lead Sponsor
GlaxoSmithKline
INDUSTRY